Background: Multiple sclerosis (MS) is an immune-mediated disorder of the CNS, leading to neurological disability. Epstein-Barr virus (EBV) infection is a putative etiologic agent for MS. This study investigated EBV- and host-encoded microRNAs (miRNAs) in serum associated with disease from persons with (PwMS) and without (PwoMS) MS.Methods: Serum samples were analyzed from a Discovery Cohort (n=48) and a Validation Cohort (n=71). Each cohort included PwoMS and PwMS, comprising groups stratified by EDSS (low and high disability) or B cell depletion therapies (BCDT). MicroRNA expression was profiled by miRNA sequencing in the Discovery Cohort from which specific miRNAs were identified through machine learning applications, followed by droplet digital PCR (ddPCR) verification in the Validation Cohort. EBV-encoded genes (EBNA1, EBER1) were quantified in serum by DNA ddPCR. Statistical analyses included linear regression, Spearman's correlation, and receiver operating characteristic (ROC) curves.Findings: While EBV-encoded miRNAs were detected in all serum samples, EBV-encoded miRNAs (miR-BART2-5p and miR-BHRF1-3) and EBNA1 DNA were positively correlated with age (p<0·05). Levels of ebv-miR-BART11-5p were increased in PwMS with low disability compared to high disability (p<0·05). Linear regression identified associations between EBNA1 DNA, ebv-miR-BART1-5p, and ebv-miR-BART20-5p and the Modified Fatigue Impact Scale (MFIS) in low-disability PwMS (p<0·05). Levels of ebv-miR-BART11-5p correlated with matched EBNA1 and EBER1 copies/mL in PwMS not receiving BCDT (p<0·05). A negative correlation was identified between ebv-miR-BART20-5p and the host miRNAs (miR-26b-5p and let-7i-5p) (p<0·05). Host-encoded miRNAs (miR-10a-5p, miR-26b-5p, miR-181d-5p, miR-200b-5p, and let-7i-5p) were differentially expressed in PwMS compared to PwoMS (p<0·05). Within PwMS, linear regression indicated that host-encoded miRNAs (miR-10a-5p, miR-22-5p, miR-26b-5p, miR-192-5p, miR-532-5p, and let-7i-5p) were associated with MFIS in BCDT- or non-BCDT-treated PwMS (p<0·05). Notably, hsa-miR-10a-5p correlated with age, EDSS, and disease duration (p<0·05). ROC curves highlighted hsa-miR-10a-5p as a potential biomarker of PwMS high disability.Interpretation: Both viral- and host-encoded miRNAs exhibited associations with disease severity and therapies among PwMS and represented potential biomarkers for diagnosis, disease severity, and treatment for PwMS.